Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario
Esmo OpenPeer ReviewedLuca Cantini +612022Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support